Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Pain, Intractable × resiniferatoxin × Clear all

Phase

Status

Withdrawn 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Intractable 1 Pain 1 Cancer Pain 1

Interventions

resiniferatoxin 1 Standard of Care 1 Sodium Chloride 1 Midazolam 1 Ketamine 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04572776 2021-11-09

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Sorrento Therapeutics, Inc.

Phase 3 Withdrawn

Cancer Pain, Pain, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡